Association between depression and risk of Parkinson's disease in South Korean adults by 박은철 et al.
Journal of Affective Disorders 292 (2021) 75–80
Available online 28 May 2021
0165-0327/© 2021 The Author(s). Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).
Association between depression and risk of Parkinson’s disease in South 
Korean adults 
Wonjeong Jeong a,b, Hyunkyu Kim b,d, Jae Hong Joo a,b, Sung-In Jang b,c, Eun-Cheol Park b,c,* 
a Department of Public Health, Graduate School, Yonsei University, Seoul, Republic of Korea 
b Institute of Health Services Research, Yonsei University, Seoul, Republic of Korea 
c Department of Preventive Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea 
d Department of Psychiatry, Yonsei University College of Medicine, Seoul, Republic of Korea   






A B S T R A C T   
Background: Depression is considered a predictive factor for cognitive impairments. At the same time, Parkinson’s 
disease (PD) is a growing public health problem. The aim of this study is to examine the association between 
depression and PD risk among South Korean adults. 
Methods: Data from 21,766 participants aged over 40, derived from the National Health Insurance Service Na-
tional Sample Cohort (2002–2013), were included. Propensity score matching (1:1) was used to match partici-
pants with and without depression (case: 10,875, control: 10,875). The dependent variable was PD risk. A Cox 
proportional hazards regression model was built to analyze the associations between variables. 
Results: People with depression had a higher risk of PD than those without depression (hazard ratio (HR) = 1.61, 
95% confidence interval (CI) = 1.26–2.06). Among individuals with disabilities, those with depression had a 
higher risk of PD (HR = 2.31, 95% CI = 1.08–4.94). According to the Charlson Comorbidity Index (CCI) score, 
those with depression had a higher risk of PD than their counterparts (CCI score ≥ 5: HR = 1.63, 95% CI =
1.21–2.20). 
Limitations: The limitations include the inability to 1) explore factors such as smoking and drinking status, which 
could be related to PD risk and 2) identify undiagnosed PD that already existed at the time of diagnosis of 
depression. 
Conclusions: The results suggest that having depression places individuals at a higher risk of PD. Interventions to 
alleviate the risk of PD should focus on adequate depression management.   
1. Introduction 
Parkinson’s disease (PD) is the second most common neurodegen-
erative disorder after Alzheimer’s disease (Aarsland et al., 2012; Nam 
et al., 2018). The degeneration of dopaminergic neurons in the brain is 
considered to play a key role in the development of Parkinson’s diseases 
(Mamelak, 2018). These neurons are vulnerable to degeneration 
because of their extensive branching and the large amounts of energy 
required to send nerve signals along this extensive network (Alonso 
et al., 2009; Mamelak, 2018). PD affects more than 1% of the global 
older adult population, and this rate is on the rise (Aarsland et al., 2012). 
Given the current trend of population aging, this disease is expected to 
affect over nine million people by 2030 (Nam et al., 2018). Even in 
South Korea, the incidence of PD has been increasing, from 41.4 per 100, 
000 people in 2004 to 142.5 in 2013, an average increase of 13.2% per 
year (Lee et al., 2017; The Korean Movement Disorder Society, 2017a). 
One of the reasons for this rapid increase may have been the aging so-
ciety; however, PD itself is difficult to diagnose, and the advances in 
technology may have led to more diagnoses (The Korean Movement 
Disorder Society, 2017b). Considering that the per-patient medical 
expense of PD is twice as high as for other diseases, reducing its burden 
by preventing the need for treatment of modifiable risk factors has 
strong significance. 
In the context of the global burden of disease, depression is a major 
contributor (World Health Organization, 2020). Specifically, in 1990, 
depression ranked fourth globally in disability-adjusted life years, and 
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was projected to rank second after ischemic heart disease by 2020 
(Chang et al., 2012). In South Korea, depression has become a major 
public health problem; between 2002 and 2013, there was a rise in 
prevalence from 2.8% to 5.3%. Considering the taboo surrounding those 
experiencing or seeking medical help for depression, the prevalence is 
likely to be underestimated (Kim et al., 2020b). Moreover, as depression 
is a major risk factor for suicidal mortality in the general population, 
treatment should be prioritized (Kim et al., 2020b). 
There are reports of depression increasing the subsequent risk of 
many physical illnesses (Shen et al., 2013) such as cancer (Chen and Lin, 
2011) and stroke (Li et al., 2012). Further, depression is highly associ-
ated with an increased risk of developing cognitive impairments like 
Alzheimer’s disease and PD (Caraci et al., 2010). Depression has also 
been reported to be not only one of the most common symptoms of PD, 
with an average prevalence of approximately 40%, but also a factor that 
could worsen PD (VanderHoek et al., 2011). One study showed that 
taking antidepressants could place individuals at risk of developing PD 
(Alonso et al., 2009). However, in other studies, antidepressant use was 
not an independent risk factor for PD; on the contrary, depression itself 
increased the risk of PD because of the associated reduction in physical 
activity and lower level of healthcare (Bica et al., 2017; Shen et al., 
2013). 
Therefore, it is necessary to investigate the association between 
depression and the risk of PD to demonstrate the importance of man-
aging the latter to prevent premature mortality. We hypothesized that 
people with depression are at a higher risk of PD than those who do not 
have depression. Consequently, the current study examined the associ-
ation between depression and the risk of PD among South Korean adults. 
2. Methods 
2.1. Data and sample 
The data for this study were obtained from the 2002–2013 National 
Health Insurance Service National Sample Cohort (NHIS-NSC). The 
NHIS-NSC data include all medical claims from 1,025,340 individuals, 
which accounts for 2% of the South Korean population, by random 
sampling. Individuals over the age of 40 years were included in the 
study. The year 2002 was designated as the washout period to prevent 
effects of other existing diseases, which might influence the results 
associated with the hypothesized relationship (Kang et al., 2018). To 
select those who were newly diagnosed with PD, we removed those who 
suffered from PD in 2003 and 2004. We selected individuals who had 
depression without PD in 2003 and 2004 as a case group. We also 
excluded those who were found to have PD within one year after 
depression, to avoid reverse causality. We then performed 1:1 pro-
pensity score matching (matching variables: age, sex, social security, 
and income) to include those without depression as a control group. 
Consequently, a total of 21,750 individuals were included in the final 
study (case: 10,875, control: 10,875). All data are available in the 
database of the Korean National Health Insurance Sharing Service (https 
://nhiss.nhis.or.kr) and can be accessed upon reasonable request. 
2.2. Ethical considerations 
This study was based on routinely collected administrative and 
claims data. All individuals provided written informed consent at the 
time of data collection by the NHIS-NSC. This study was reviewed and 
approved by the International Review Board of Yonsei University’s 
Health System (IRB number: 4-2021-0159) and adheres to the tenets of 
the Declaration of Helsinki. As the NHIS-NSC data do not contain any 
identifying information, additional approval was not required. 
2.3. Variables 
The risk of PD (International Classification of Diseases, 10th revision 
(ICD-10) code: G20) was the dependent variable. Individuals with drug- 
induced parkinsonism were not included. Only the data of people newly 
diagnosed with PD after 2006 were included in this study. 
The primary independent variable was the diagnosis of depression 
(ICD-10: F32, F33) compared to the general population. Depression was 
categorized into no depression, mild depression (ICD-10: F32.0, F33.0), 
moderate depression (ICD-10: F32.1, F33.1), severe depression (ICD-10: 
F32.2, F32.3, F33.2, F33.3), and unspecified depression. Additionally, 
the analyses included age, social security, income, region, disability, 
Charlson Comorbidity Index (CCI) score, and diabetes (ICD-10: E10, 
E11) (Sundararajan et al., 2004). 
Social security was categorized into health insurance (corporate, 
regional)and medical aid. The social security system in South Korea, the 
National Health Insurance System, covers the entire population residing 
within the territory of Korea except for beneficiaries of medical aid 
(National Health Insurance Services, 2015). The source of financing is 
mainly contributions from the insured and subsidies from the govern-
ment. Moreover, the medical aid program is financed by both the central 
and local governments and is part of the Korean public assistance system 
(National Health Insurance Services, 2015). The government plays a 
direct insurance role for the poor. Therefore, the Korean government 
offers the medical aid program for people unable to pay for their own 
healthcare coverage. Disability was categorized as individuals who were 
registered as disabled on the NHIS information database and those who 
were not (National Health Insurance Service National Sample Cohort, 
2017). The CCI index was calculated by attaching weights and scoring 
comorbid conditions using Quan’s method, with additional points added 
to consider comorbidities that affect patients’ health outcomes (Lee 
et al., 2020; Quan et al., 2011). 
2.4. Statistical analysis 
The chi-square test was used to investigate the general characteris-
tics of the study population. A Cox proportional hazards regression 
model was used to calculate the association between depression and the 
risk of PD. Differences were considered statistically significant with a p- 
value < 0.05. All data analyses used SAS 9.4 software (SAS Institute Inc., 
Cary, NC, USA). 
3. Results 
Table 1 presents the general characteristics of the study population. 
Among the 21,750 participants, 303 (1.4%) had PD. The relationship 
between depression and the risk of PD was statistically significant. 
Table 2 shows the association between depression and the risk of PD 
after controlling for all covariates. Individuals with depression had a 
higher risk of PD than those without depression (hazard ratio [HR] =
1.6, 95% confidence interval [CI] = 1.26–2.06). The risk of PD increased 
with age (61–70 years: HR = 3.92, 95% CI = 2.73–5.63, > 71 years: HR 
= 4.38, 95% CI = 3.07–6.25). Individuals with disabilities had a higher 
risk of PD compared to those without disabilities (HR = 1.37, 95% CI =
1.03–1.84). Moreover, the risk of PD increased with increasing CCI score 
(CCI score: 3–4: HR = 2.26, 95% CI = 1.40–3.63; CCI score ≥5: HR =
5.75, 95% CI = 3.70–8.94). 
Table 3 shows the results of subgroup analysis between depression 
and the risk of PD, focusing on sex, social security, disability, and CCI 
score. Male participants with depression had a higher risk of PD than 
those without depression (HR = 2.50, 95% CI = 1.57–4.00). Among 
individuals who received medical aid or were regional subscribers, those 
with depression had a higher risk of PD than those without (HR = 1.80, 
95% CI = 1.35–2.42). Individuals with disabilities who had depression 
were at a higher risk of PD than those without depression (HR = 2.31, 
95% CI = 1.08–4.94). According to the CCI score, those who had 
depression were at a higher risk of PD (CCI score ≥ 5: HR = 1.63, 95% CI 
= 1.21–2.20). 
Table 4 shows the results of the association between the detailed 
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depression type and PD risk. While 569 (2.6%) participants had severe 
depression, 1538 (7.1%) had moderate and 4733 (21.8%) had mild 
depression. Individuals with mild or moderate depression were at a 
higher risk of PD than those without depression (mild depression: HR =
1.58, 95% CI = 1.18–2.13; moderate depression: HR = 1.76, 95% CI =
1.16–2.67). Moreover, those with unspecified depression had a higher 
risk of PD than those without depression (unspecified depression: HR =
1.71, 95% CI = 1.27–2.30). 
Fig. 1 presents the results of the association between depression and 
the risk of PD according to the annual follow-up from diagnosis of 
Table 1. 
General characteristics of the study population according to the risk of Parkinson’s disease.a  
Variables Total Risk of Parkinson’s Disease P-value 
Yes No 
Total 21,750 (100.0) 303 (1.4) 21,447 (98.6) 
Depression       < 0.0001  
Yes 10,875 (50.0) 204 (1.9) 10,671 (98.1)   
No 10,875 (50.0) 99 (0.9) 10,776 (99.1)  
Sex        0.7762  
Male 6,942 (31.9) 99 (1.4) 6,843 (98.6)   
Female 14,808 (68.1) 204 (1.4) 14,604 (98.6)  
Age       < 0.0001  
41–60 11,552 (53.1) 44 (0.4) 11,508 (99.6)   
61–70 4,694 (21.6) 105 (2.2) 4,589 (97.8)   
≥ 71 5,504 (25.3) 154 (2.8) 5,350 (97.2)  
Social Security       < 0.0001  
Insurance (Corporate) 8,772 (40.3) 79 (0.9) 8,693 (99.1)   
Insurance (Regional) & Medical Aid 12,978 (59.7) 224 (1.7) 12,754 (98.3)  
Income       0.1137  
Low 3,912 (18.0) 53 (1.4) 3,859 (98.6)   
Middle 7,784 (35.8) 93 (1.2) 7,691 (98.8)   
High 10,054 (46.2) 157 (1.6) 9,897 (98.4)  
Region       0.4931  
Metropolitan 8,789 (40.4) 124 (1.4) 8,665 (98.6)   
City 5,264 (24.2) 65 (1.2) 5,199 (98.8)   
Rural 7,697 (35.4) 114 (1.5) 7,583 (98.5)  
Disability       < 0.0001  
Yes 2,111 (9.7) 60 (2.8) 2,051 (97.2)   
No 19,639 (90.3) 243 (1.2) 19,396 (98.8)  
Charlson Comorbidity Index       < 0.0001  
0–2 7,364 (33.9) 23 (0.3) 7,341 (99.7)   
3–4 7,763 (35.7) 68 (0.9) 7,695 (99.1)   
≥ 5 6,623 (30.5) 212 (3.2) 6,411 (96.8)  
Diabetes       < 0.0001  
Yes 144 (0.7) 9 (6.3) 135 (93.8)   
No 21,606 (99.3) 294 (1.4) 21,312 (98.6)   
a The matching variables were sex, age, social security, and income.  
Table 2. 
Results of the association between depression and the risk of Parkinson’s 
disease.    
Risk of Parkinson’s Disease 
Variables HR 95% CI 
Depression      
Yes 1.61 (1.26 - 2.06)  
No 1.00    
Sex       
Male 1.05 (0.82 - 1.35)  
Female 1.00    
Age       
41–60 1.00     
61–70 3.92 (2.73 - 5.63)  
≥ 71 4.38 (3.07 - 6.25) 
Social Security      
Insurance (Corporate) 1.00     
Insurance (Regional) & Medical Aid 1.22 (0.91 - 1.64) 
Income       
Low 1.00     
Middle 0.83 (0.59 - 1.18)  
High 0.91 (0.65 - 1.27) 
Region       
Metropolitan 1.00     
City 0.92 (0.68 - 1.24)  
Rural 0.89 (0.69 - 1.16) 
Disability      
Yes 1.37 (1.03 - 1.84)  
No 1.00    
Charlson Comorbidity Index      
0–2 1.00     
3–4 2.26 (1.40 - 3.63)  
≥ 5 5.75 (3.70 - 8.94) 
Diabetes      
Yes 2.13 (1.09 - 4.15)  
No 1.00     
Table 3. 
Subgroup analysis of the association between risk of Parkinson’s disease and 
covariates according to depression.    
Depression   
Yes No  
Adjusted 
HR 
95% CI Adjusted 
HR  Lower  Upper 
Sex        
Male 2.50 (1.57 - 4.00) 1.00  
Female 1.36 (1.01 - 1.82) 1.00 
Social Security       
Insurance (Corporate) 1.22 (0.77 - 1.94) 1.00  
Insurance (Regional) 
& Medical Aid 
1.80 (1.35 - 2.42) 1.00 
Disability       
Yes 2.31 (1.08 - 4.94) 1.00  
No 1.55 (1.19 - 2.01) 1.00 
Charlson Comorbidity 
Index       
0–2 2.83 (1.17 - 6.86) 1.00  
3–4 1.33 (0.81 - 2.18) 1.00  
≥ 5 1.63 (1.21 - 2.20) 1.00  
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depression. Compared to those without depression, those who had a 
longer period till follow-up after the initial diagnosis of depression, had 
a higher risk of PD. 
4. Discussion 
Depression is the complex outcome of the interaction of many risk 
factors (Leentjens, 2015). It is the most common psychiatric disorder 
associated with PD (Leentjens, 2015; Schrag, 2006). Owing to the 
diminished quality of life of people with depression, under-diagnosed 
and under-treated depression lead to worsening of symptoms, which, 
in turn, might lead to PD (Menon et al., 2015). However, there is a 
paucity of studies that demonstrate PD’s relationship with depression 
through comparisons between people with and without depression. 
Therefore, this study examined the association between depression and 
PD risk among South Korean adults. 
Many people experience depression and anxiety prior to the onset of 
PD, which indicates that psychiatric conditions may be risk factors 
(Jacob et al., 2010). Depression and anxiety are significant non-motor 
symptoms in PD, as they may be associated with more rapid deteriora-
tion in cognitive and motor functions (Jacob et al., 2010; Uekermann 
et al., 2003). Since affective disorders can influence the morphological 
alteration of the raphe nuclei in the brainstem, depression could have a 
strong association with PD (Uekermann et al., 2003). In previous 
studies, people with depression had significantly greater cognitive 
decline compared to those without depression, displaying more severe 
impairment on tests of verbal auditory attention and fluency than the 
healthy controls (Kuzis et al., 1997; Uekermann et al., 2003). Never-
theless, depressive symptoms in PD often remain untreated, as an ac-
curate assessment of depression and PD is difficult due to overlapping 
disease symptomatology and availability of multiple assessment tools 
and techniques (Early et al., 2017). Therefore, it is crucial to promptly 
recognize and adequately address depression to prevent the deteriora-
tion of psychological symptoms over time (VanderHoek et al., 2011). 
Depression can be highly associated with PD in various dimensions. 
Biologically, there could be a genetic susceptibility. Other potentially 
Table 4. 
Results of association of detailed depression type and the risk of Parkinson’s disease.  
Variables Total Risk of Parkinson’s Disease 
Yes No HR 95% CI 
Total 21,750 (100.0) 303 (1.4) 21,447 (98.6) 
Depression          
No 10,875 (50.0) 99 (0.9) 10,776 (99.1) 1.00   
Mild depression 4,733 (21.8) 83 (1.8) 4,650 (98.2) 1.58 (1.18-2.13)  
Moderate depression 1,538 (7.1) 29 (1.9) 1,509 (98.1) 1.76 (1.16-2.67)  
Severe depression 569 (2.6) 7 (1.2) 562 (98.8) 1.05 (0.49-2.27)  
Unspecified depression 4,035 (18.6) 85 (2.1) 3,950 (97.9) 1.71 (1.27-2.30)  
Fig. 1. Association between depression and risk of Parkinson’s disease according to the years follow-up from diagnosis of depression. 
Adjusted for age, sex, social security, income, region, disability, charlson comorbidity index, and diabetes. Whiskers in each bar represent error estimate of regression 
coefficients. Reference group is "No depression". 
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important factors include the pathophysiology of PD and medication 
use, and the social aspect, such as relational factors and past psycho-
logical trauma (Leentjens, 2015). The high prevalence of depression and 
anxiety in patients with PD before the onset of motor symptoms further 
supports a complex pathophysiological connection (MartínezMartín and 
Damián, 2010). Pathophysiological factors common to PD and other 
diseases occurred with a higher incidence after depression (Leentjens, 
2015). Moreover, regarding social factors such as past psychological 
trauma, it is known that posttraumatic stress disorder (PTSD) is highly 
associated with neurodegenerative disorders such as Alzheimer’s dis-
ease and PD (Chan et al., 2017). Exposure to extreme stress such as that 
in PTSD is associated with neuroanatomical change, which can induce 
alterations in the brain (Kibel and Drenjančević-Perić, 2008). Likewise, 
previous studies show that psychiatric symptoms such as psychosomatic 
disorders, anxiety, dysthymic disorder, and depression were highly 
associated with the development of PD (Bower et al., 2010; Nilsson 
et al., 2001; Shiba et al., 2000). Moreover, depression and anxiety are 
the early manifestations of PD (Cosci et al., 2015). Although there is a 
lack of evidence about depression directly affecting PD (Kibel and 
Drenjančević-Perić, 2008), it is clear that the depression and PD are 
strongly associated. 
Unspecified depression is diagnosed when the clinician chooses not 
to specify the reason as the criteria are not met for a specific depressive 
disorder (Virginia Commission on Youth, 2017). Therefore, there is 
insufficient information to design more specific treatments, which could 
involve wrongly inferring low severity and, therefore, discourage 
treatment (Thomas and Seedat, 2018). The treatment using medication 
for anxiety or depression could be highly associated with lower devel-
opment of PD (Bower et al., 2010). Moreover, among individuals with 
mental disorders such as depression or dementia, those who received 
proper care were clearly associated with low levels of PD severity 
(Riedel et al., 2012). Our study also found out that individuals with 
unspecified depression had higher risk of PD compared to those without 
depression. However, we found that severe depression and PD were not 
significantly associated, as the patients consistently receive proper 
medication and treatment. The current study also revealed that among 
individuals who received medical aid, those with depression had a 
higher risk of PD. Considering that patients covered by medical aid had 
generally more difficult economic circumstances, their use of medical 
services tended to be low in South Korea, which led to a lack of 
appropriate and timely care (Chang et al., 2011). Therefore, proper, 
timely care for depression is associated with low PD, given the strong 
association between the two diseases. 
PD is diagnosed according to its motor features such as bradykinesia, 
tremors, rigidity, and postural instability (Pontone et al., 2016). The 
progression of motor symptoms parallels the worsening of daily func-
tions, and for non-motor symptoms, depression causes additional im-
pairments in activities of daily living (ADL) (Pontone et al., 2016; 
Quelhas and Costa, 2009) In the present study, individuals with dis-
abilities who also suffered from depression were at a higher risk of PD 
than individuals with disabilities who did not have depression. As ADL 
functions in individuals with depression have been reported to decline 
faster than in individuals who have never experienced depression, dis-
abilities could further increase the risk of PD (Pontone et al., 2016). 
Moreover, diabetes and its complications may themselves be affected 
by the neurodegenerative processes leading to neuronal degeneration 
(Riederer et al., 2011). In a previous study, diabetes and insulin resis-
tance were highly associated with an increased risk of PD (Driver et al., 
2008). Considering that patients with diabetes have been known to have 
a significantly higher risk of both depression and anxiety, the presence 
of both depression and diabetes could accelerate the risk of PD (Clarke 
and Currie, 2009; Riederer et al., 2011). Moreover, PD is strongly 
associated with other chronic illnesses, the presence of comorbidities is 
an important factor of rising healthcare costs and challenges to our 
healthcare, which could affect overall well-being and mobility (King 
et al., 2014). 
4.1. Limitations 
First, unhealthy behaviors such as smoking and alcohol consump-
tion, which could affect the risk of PD, were not included in this study 
because these were not present in the original dataset. Second, this study 
could not adjust the severity of PD owing to lack of data. Third, the 
possibility of undiagnosed PD that already existed at the time of diag-
nosis of depression was not considered. As our study used claims data, 
individuals who were not diagnosed could not be considered. Fourth, 
the prevalence of depression was higher in women than men in most age 
groups in South Korea, which might have affected the sample of our 
study (Kim et al., 2020a). Therefore, our study used sex as a matching 
variable. Finally, psychological disorders other than depression were not 
included. Further research with various such disorders is required. 
4.2. Conclusions 
Despite these limitations, this study has certain strengths. The first is 
the use of nationally representative data to assess the association be-
tween depression and the risk of PD, which can provide the necessary 
evidence to ensure that with timely care, depression does not lead to 
other diseases. Second, as the data spanned nearly 10 years, it is possible 
to make inferences about a long-term association. Third, this study 
included not only depression but also its severity, which could provide 
more accurate and detailed information. Lastly, this study emphasizes 
the importance of managing the risk of PD, which, despite being among 
the most common neurodegenerative disorders, is often ignored. 
The current study identified a significant relationship between 
depression and the risk of PD among South Korean adults. Based on our 
results, individuals with mild or moderate depression were at a higher 
risk of PD than those without depression. Moreover, individuals with 
unspecified depression were at a higher risk of PD than those without 
depression. This highlights the importance of taking the necessary steps 
to ensure that those diagnosed with depression. Interventions to alle-
viate the risk of PD should focus on adequate depression management. 
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